These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36264557)

  • 21. Validation of the olfactory disorders questionnaire for English-speaking patients with olfactory disorders.
    Langstaff L; Pradhan N; Clark A; Boak D; Salam M; Hummel T; Philpott CM
    Clin Otolaryngol; 2019 Sep; 44(5):715-728. PubMed ID: 31038840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 8-Odorant Barcelona Olfactory Test (BOT-8): Validation of a New Test in the Spanish Population During the COVID-19 Pandemic.
    Rojas-Lechuga MJ; Ceballos JC; Valls-Mateus M; Mackers P; Izquierdo-Domínguez A; López-Chacón M; Langdon C; Mariño-Sánchez F; Valero J; Mullol J; Alobid I
    J Investig Allergol Clin Immunol; 2022 Jul; 32(4):291-298. PubMed ID: 35532333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
    Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
    J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial.
    Tragoonrungsea J; Tangbumrungtham N; Nitivanichsakul T; Roongpuvapaht B; Tanjararak K
    Clin Otolaryngol; 2023 Mar; 48(2):182-190. PubMed ID: 36336851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
    Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
    Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Psychometric Evaluation of the Symptom Intrusiveness Rating Scale Among Individuals Experiencing Pain Associated With Chronic Wounds.
    Monfre JM; Kelechi TJ; Magwood GS; Mueller M
    J Wound Ostomy Continence Nurs; 2015; 42(5):474-9. PubMed ID: 26336044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of a three-item smell identification test in detecting olfactory dysfunction.
    Jackman AH; Doty RL
    Laryngoscope; 2005 Dec; 115(12):2209-12. PubMed ID: 16369168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and reliability of the Questionnaire of Olfactory Disorders for Italian-speaking patients with olfactory dysfunction.
    Vaira LA; Tirelli G; Rizzo D; Uderzo F; Avanzini F; Trabalzini F; Rivelli N; Burger D; Calabrese L; Solla P; Bussu F; Mayo-Yáñez M; Lechien JR; De Riu G; Boscolo-Rizzo P
    Acta Otorhinolaryngol Ital; 2024 Feb; 44(1):42-51. PubMed ID: 38420720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple Disposable Odor Identification Tests for Predicting SARS-CoV-2 Positivity.
    Ziuzia-Januszewska L; Dobrzyński P; Ślączka K; Ciszek J; Krawiec Ł; Wierzba W; Zaczyński A
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and validity of the Korean version of the Questionnaire of Olfactory Disorders.
    Choi WR; Jeong HY; Kim JH
    Int Forum Allergy Rhinol; 2018 Dec; 8(12):1481-1485. PubMed ID: 30039926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective validation of a patient-reported nasal quality-of-life tool for endonasal skull base surgery: The Anterior Skull Base Nasal Inventory-12.
    Little AS; Kelly D; Milligan J; Griffiths C; Rosseau G; Prevedello DM; Carrau R; Jahnke H; Chaloner C; O'Leary J; Chapple K; Nakaji P; White WL
    J Neurosurg; 2013 Oct; 119(4):1068-74. PubMed ID: 23662829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
    Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
    JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression Symptoms and Olfactory-related Quality of Life.
    Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA
    Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients.
    Abetz L; Rajagopalan K; Mertzanis P; Begley C; Barnes R; Chalmers R;
    Health Qual Life Outcomes; 2011 Dec; 9():111. PubMed ID: 22152125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation and validation of the Chinese version of the Quality OF Life Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N).
    Chen XL; Qiu ZW; Gu MF; Su Y; Liu LZ; Liu Y; Mo CW; Xu Q; Sun J; Li DH
    Health Qual Life Outcomes; 2014 Apr; 12():51. PubMed ID: 24731442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
    Tchekmedyian R; Lundberg M; Buchheit KM; Maurer R; Gakpo D; Mullur J; Bensko JC; Laidlaw TM
    Clin Exp Allergy; 2022 Dec; 52(12):1414-1421. PubMed ID: 35506180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual Morbidity Assessment in Gyne-Oncology Follow-Up: Development of the Sexual Well-Being After Cervical or Endometrial Cancer (SWELL-CE) Patient-Reported Outcome Measure.
    White ID; Tennant A; Taylor C
    J Sex Med; 2020 Oct; 17(10):2005-2015. PubMed ID: 32741745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire.
    Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JC; Wang CQ; Welsh B; Nijsten T; Murrell DF
    JAMA Dermatol; 2013 Oct; 149(10):1186-91. PubMed ID: 23925444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.